TRYPTAMINE THERAPEUTICS LIMITED

News Tryptamine Therapeutics Limited

Equities

TYP

AU0000331993

Market Closed - Australian S.E. Other stock markets 11:40:22 2024-06-18 pm EDT			5-day change	1st Jan Change
0.02 ^AUD	0.00%		-4.76%	0.00%

05:05am	Tryptamine Therapeutics Partners with Lucid Health to Advance TRP-8803's Product Registration in Australia	MT
May. 29	Tryptamine Therapeutics Begins to Trade on ASX; Shares Surge 118%	MT

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Tryptamine Therapeutics Partners with Lucid Health to Advance TRP-8803's Product Registration in Australia	11:05pm	MT
Tryptamine Therapeutics Begins to Trade on ASX; Shares Surge 118%	May. 28	MT
Tryp Therapeutics Files Amended Financial Statements for the Six Months Ended February 29, 2024	May. 17	NE
Tryptamine Therapeutics Limited Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024	Apr. 29	CI
3,043,860 Common Shares of Tryptamine Therapeutics Limited are subject to a Lock-Up Agreement Ending on 18-DEC-2023.	Dec. 17	CI
3,043,860 Common Shares of Tryptamine Therapeutics Limited are subject to a Lock-Up Agreement Ending on 20-JUN-2023.	23-06-19	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Stock Market
Equities
TYP Stock
News Tryptamine Therapeutics Limited

Our Free Content Help you Secure and Increase the Performance of Your Investments

Securing my Investments

fermer